Comparing Two Doses of Glatiramer Acetate
- Study Title
- Clinical Trial Comparing Treatment of Relapsing-Remitting Multiple Sclerosis (RR-MS) With Two Doses of Glatiramer Acetate (GA).
- Teva Identifier
- GA/9016 (FORTE)
- ClinicalTrials.gov Identifier
- NCT00337779
- Study Status
- Completed
- Trial Condition(s)
- Relapsing Remitting Multiple Sclerosis
- Interventions
- Drug: Glatiramer Acetate (GA) 40 mg | Drug: glatiramer acetate 20 mg
Study Description
Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
- Gender
- Female, Male
- Age group
- Adult
- Age Range
- 18 Years to 55 Years
- Trial Duration
- 08/01/2006 - 10/01/2008
- Phase
- Phase 3
